Skip to main content

Dyne Therapeutics, Inc.

DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001818794

In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Dyne Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
90
−2 vs. Q1 2022
Shares held
46.7M
−1.03M (−2.2%) vs. Q1 2022
Total value
$320.7M
−$135.8M (−29.7%) vs. Q1 2022
New holders
9
26 more added
Sold out
11
31 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DYN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 90 institutions
Q1 2021: 75 institutionsQ2 2021: 76 institutionsQ3 2021: 83 institutionsQ4 2021: 93 institutionsQ1 2022: 94 institutionsQ2 2022: 90 institutionsQ3 2022: 102 institutionsQ4 2022: 113 institutionsQ1 2023: 127 institutionsQ2 2023: 118 institutionsQ3 2023: 114 institutionsQ4 2023: 124 institutionsQ1 2024: 169 institutionsQ2 2024: 193 institutionsQ3 2024: 200 institutionsQ4 2024: 200 institutionsQ1 2025: 205 institutionsQ2 2025: 198 institutionsQ3 2025: 207 institutionsQ4 2025: 233 institutionsQ1 2026: 228 institutionsQ2 2026: 245 institutions
Value heldQ2 2022: $320.7M
Q1 2021: $533.3MQ2 2021: $753.4MQ3 2021: $572.8MQ4 2021: $568.3MQ1 2022: $456.6MQ2 2022: $320.7MQ3 2022: $565.8MQ4 2022: $576.2MQ1 2023: $628.7MQ2 2023: $665.9MQ3 2023: $536.6MQ4 2023: $930.0MQ1 2024: $2.71BQ2 2024: $3.92BQ3 2024: $4.03BQ4 2024: $2.63BQ1 2025: $1.29BQ2 2025: $1.22BQ3 2025: $1.97BQ4 2025: $3.48BQ1 2026: $3.40BQ2 2026: $4.23B
Institutions holding DYN and their total value by quarter
QuarterHoldersValue
Q2 2026245$4.23B
Q1 2026228$3.40B
Q4 2025233$3.48B
Q3 2025207$1.97B
Q2 2025198$1.22B
Q1 2025205$1.29B
Q4 2024200$2.63B
Q3 2024200$4.03B
Q2 2024193$3.92B
Q1 2024169$2.71B
Q4 2023124$930.0M
Q3 2023114$536.6M
Q2 2023118$665.9M
Q1 2023127$628.7M
Q4 2022113$576.2M
Q3 2022102$565.8M
Q2 202290$320.7M
Q1 202294$456.6M
Q4 202193$568.3M
Q3 202183$572.8M
Q2 202176$753.4M
Q1 202175$533.3M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Dyne Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding DYN in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Toronto Dominion Bank0$00.00%−3−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed